To enable reliable and ethical drug releases thus reducing unnecessary animal-based testing.
CTL-MAT offers reliable, quantitative, nonanimal-based pyrogen testing solutions using the Monocyte Activation Test.
Our products and services permit Ph. Eur. 2.6.30-compliant, robust and accurate detection of pyrogenic contaminants in parenteral drugs, biopharmaceuticals, cosmetics and solid medical devices.
CTL-MAT can support its customers with all their MAT related needs.